Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
It also prevents the body from releasing too much glucagon, a hormone that increases blood sugar levels
Reduction in Risk Across Fourteen Obesity-Related Cancers A large observational study presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2025, involving more than 170,000 patients with diabetes and obesity, found that GLP-1 receptor agonists were associated with a modest but statistically meaningful reduction in the incidence of 14 obesity-related cancers , with colorectal cancer demonstrating particularly favourable outcomes when compared to patients receiving DPP-4 inhibitors
Who Is Eligible Roughly 10% of Medicare enrollees (~3.4 million people) are expected to qualify for GLP-1 coverage
To do this, they used a group of tools known as epigenetic clocks, which estimate how quickly the body is aging by analyzing DNA methylation patterns
US$ 20.15
US$ 21.29
US$ 24.40
US$ 28.30
US$ 26.96
US$ 27.90
